Program Description
The pathogenesis of anemia in patients with cancer is complex and multifactorial. Evaluation and treatment of patients with anemia can be challenging, especially for patients with complicated cancers, including solid tumors or hematologic malignancies. Traditional therapies used to manage anemia in patients without cancer do not have the same efficacy in patients with cancer, and understanding evidence-based strategies to overcome these challenges is necessary for the health and well-being of patients with cancer. The pharmacist's role in understanding IDA in patients with cancer is crucial, as it involves managing the underlying etiology, replenishing iron stores, and improving quality of life. This webinar will examine recommendations for identifying IDA and managing iron replacement therapies following evidence-based treatment pathways. This webinar is part of the Iron Deficiency Anemia Webinar series.
Target audience: Ambulatory Care Pharmacist, Community Pharmacist, Health-System Pharmacist, Oncology Pharmacist
Type of activity: Application
Release date: June 25, 2025
Expiration date: June 25, 2026
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify treatment-induced causes of anemia in patients with cancer
- Provide iron replacement recommendations for patients with cancer
- Construct care plans for oncology patients with iron deficiency anemia based on treatment regimen
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here